Member Info for AimMaster2018

Brent 32.30

Tlw 28.70

Where is this heading? Hmm

Good luck all

what do u reckon guys

Liam. i don't ever think you'll get an answer pal, As an investor, you would be able to explain clearly what the business are doing for share rise to be justified, then u can promote for potential rise but I don't feel convinced, so am sorry. Am out.

I think every company should attend, we'd double pur money ha

Latino - u mean double triple percentage losses

This is what u said '
Liam - Look at the current MCAP - Low. Look at the TR-1 RNS's at check out the person and his links to GSK for one!'

Can you justify the rise please?

I can only sense pump and dump putting peoples hard earnt money at greater risk than the actual fact and purpose of the RNS today?

that tr1 was before today rise but because they have links to a certain company doesn't imply pyc has anything to do with covid otherwise it would have been on the presentation no?

Yep, it's about cancer and nothing about covid 19? Can u show me which bit is about covid please?

everyones expecting a rise, but no one can answer the reason why????

Share price jumped on the word of 'covid ' but the business has no involvement to covid whatsoever, no vaccine, no drug, no antibodies, nothing, don't understand the rise. Can anyone explain?

Looks like its prime to move imho. Hopefully into the 90s and above, good luck all

D220, it should rise from here imho, remember fully funded and they've sign documents, just waiting on a team to to its due diligence on site,

Aren't monkeys close to humanisation than mice and why test on monkeys first

Wheres the revenue, a test on few miles to see of vaccine works right

Indeed my friend

Can some1 correct me please

It seems significantly earlier than we had been cautioned to expect, but the Oxford University's Jenner Insititute believes it has produced an effective vaccine, and plans to carry out clinical tests on 6,000 people before the end of May.

The Jenner vaccine was tested on six rhesus macaque monkeys at the US National Institutes of Health’s Rocky Mountain Laboratory in Montana last month, according to the New York Times.

The monkeys were exposed to high doses of the virus, and all six remained healthy 28 days later. Monkeys without the vaccine fell sick, according to the report.